Sonothera named a 2026 Winner of Endpoints 11 Awards
Sonothera named one of the 2026 Winners of the Endpoints 11 Awards, showcasing biotech’s most exciting startups.
News
listing-news
Latest News
Attovia Therapeutics announces Initial Public Offering
Attovia Therapeutics (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, announced the pricing of its upsized initial public offering.
NuCicer Introduces Nuchi, a New Class of High-Protein Chickpeas Designed for Clean-Label Food Formulation
NuCicer Introduces Nuchi, announced Nuchi™ , a whole new class of high-protein chickpeas. Nuchi (“new + chickpea”) is the product of foundational plant genetics research accelerated by NuCicer's AI-driven genomic modeling and speed-breeding technology.
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, an important biomarker in Alzheimer’s Disease Research
Alamar Biosciences, (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, launched the first commercial eMTBR-Tau immunoassay, now available in the NULISAseq™ Neuro 220 multiplexed panel kits, deployable on the installed base of ARGO™ HT instruments, and as a single-plex assay through the company’s Technology Access Program.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
0 selected
Generating previews...